DFDA

Ceftriaxone

Treatment for Invasive Non Typhoidal Salmonella Ints

Typical Dosage: 1-2g IV/IM daily

Effectiveness
90%
Safety Score
70%
Clinical Trials
300
Participants
30K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
1-2g IV/IM daily
Time to Effect
2-3 days
Treatment Duration
7-14 days
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$500
Side Effect Mgmt:$50
Total Annual:$700
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$778
Cost per Remission
$778
Prescription Access Economics
Physician Visit Cost
$150/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$150/year
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
HIGH
Requires Monitoring
Yes
Needs lab work/checkups
Ceftriaxone Outcomes

for Invasive Non Typhoidal Salmonella Ints

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+90%
Common Side Effects
Diarrhea
+5%
Injection site pain
+3%
Rash
+1%

Sources:

researchgate.net
nih.gov
tandfonline.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov